BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38308396)

  • 1. Comparison of timing of relapse in dogs with nonassociative immune-mediated hemolytic anemia, thrombocytopenia, or polyarthritis.
    Sparrow R; Swann JW; Glanemann B
    J Vet Intern Med; 2024; 38(2):1035-1042. PubMed ID: 38308396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Thymidine Kinase 1, Canine-C-Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune-Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy.
    Grobman M; Outi H; Rindt H; Reinero C
    J Vet Intern Med; 2017 Sep; 31(5):1430-1440. PubMed ID: 28804921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenectomy in the management of primary immune-mediated hemolytic anemia and primary immune-mediated thrombocytopenia in dogs.
    Bestwick JP; Skelly BJ; Swann JW; Glanemann B; Bexfield N; Gkoka Z; Walker DJ; Silvestrini P; Adamantos S; Seth M; Warland J
    J Vet Intern Med; 2022 Jul; 36(4):1267-1280. PubMed ID: 35801263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine-associated immune-mediated hemolytic anemia in the dog.
    Duval D; Giger U
    J Vet Intern Med; 1996; 10(5):290-5. PubMed ID: 8884713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
    Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E
    J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of systemic hypertension in dogs with nonassociative (primary) immune-mediated hemolytic anemia (December 2016 to April 2019): 26 cases.
    Hall GBF; Stoye DQ; Thomas EK; Culshaw GJ
    J Vet Emerg Crit Care (San Antonio); 2022 Mar; 32(2):229-235. PubMed ID: 35080103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary 11-dehydrothromboxane B
    Conway EA; Evans NP; Ridyard AE
    J Vet Intern Med; 2022 Jan; 36(1):86-96. PubMed ID: 34859495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human intravenous immunoglobulin use for hematological immune-mediated disease in dogs.
    Kane BK; Greer RM
    J Am Vet Med Assoc; 2023 Jul; 261(7):1004-1010. PubMed ID: 37072115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-mediated hemolytic anemia and severe thrombocytopenia in dogs: 12 cases (2001-2008).
    Orcutt ES; Lee JA; Bianco D
    J Vet Emerg Crit Care (San Antonio); 2010 Jun; 20(3):338-45. PubMed ID: 20636987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presumptive hemophagocytic syndrome associated with immune-mediated anemia in two Miniature Dachshunds.
    Akiyoshi M; Hisasue M; Neo S; Akiyoshi M
    J Vet Med Sci; 2021 Apr; 83(4):689-694. PubMed ID: 33692231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of membrane-based therapeutic plasma exchange as adjunctive treatment for immune-mediated hematologic disorders in dogs.
    Francey T; Etter M; Schweighauser A
    J Vet Intern Med; 2021 Mar; 35(2):925-935. PubMed ID: 33571376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum interleukin 17 concentrations in dogs with immune-mediated hemolytic anemia.
    Cuq B; Blois SL; Bédard C; Wood RD; Abrams-Ogg AC; Beauchamp G; Wood GA
    J Vet Intern Med; 2021 Jan; 35(1):217-225. PubMed ID: 33219716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia.
    Scott-Moncrieff JC; Reagan WJ; Snyder PW; Glickman LT
    J Am Vet Med Assoc; 1997 Jun; 210(11):1623-7. PubMed ID: 9170090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of immunosuppressive and anti-thrombotic protocols in nonassociative immune mediated hemolytic anemia in dogs.
    Weng J; Levy NA; Abbott HY; Mix JA; Wills RW; Mackin AJ; Thomason JM; Cridge H
    J Vet Intern Med; 2023 Mar; 37(2):528-536. PubMed ID: 36809664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of prognostic factors for mortality in dogs with immune-mediated hemolytic anemia.
    Swann JW; Skelly BJ
    J Vet Intern Med; 2015 Jan; 29(1):7-13. PubMed ID: 25586014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs.
    West LD; Hart JR
    J Vet Emerg Crit Care (San Antonio); 2014; 24(2):226-31. PubMed ID: 24251650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-Mediated Hemolytic Anemia and Clinically Suspected Acute Pancreatitis in Dogs, a Pilot Study.
    Gianesini G; Drigo M; Zoia A
    Top Companion Anim Med; 2023; 56-57():100821. PubMed ID: 37802244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil Extracellular Traps in Plasma from Dogs with Immune-mediated Hemolytic Anemia.
    Lawson C; Smith SA; O'Brien M; McMichael M
    J Vet Intern Med; 2018 Jan; 32(1):128-134. PubMed ID: 29214674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenectomy as an adjunctive treatment for dogs with immune-mediated hemolytic anemia: ten cases (2003-2006).
    Horgan JE; Roberts BK; Schermerhorn T
    J Vet Emerg Crit Care (San Antonio); 2009 Jun; 19(3):254-61. PubMed ID: 19691510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-mediated hemolytic anemia: 70 cases (1988-1996).
    Reimer ME; Troy GC; Warnick LD
    J Am Anim Hosp Assoc; 1999; 35(5):384-91. PubMed ID: 10493413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.